IMAC Holdings (BACK) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

13 February 2019

Indexes:

Not included

Description:

BACK (IMAC Holdings) specializes in innovative solutions for the healthcare industry, focusing on rehabilitation and recovery. They provide advanced technologies and services to enhance patient care, improve outcomes, and support healthcare professionals in delivering effective treatments. Their mission is to transform rehabilitation through cutting-edge products and services.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 10, 2021

Recent annual earnings:

Mar 04, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sept 08, 2023

Analyst ratings

Recent major analysts updates

19 Aug '21 National Alliance Securities
Neutral
15 Apr '20 Ascendiant Capital
Buy
14 Jan '20 Dawson James
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology
BACK
globenewswire.com19 September 2024

Nashville, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”), a leader in innovative healthcare solutions, proudly announces the launch of an entirely new precision oncology assay for breast cancer treatment decision making utilizing the Reverse Phase Protein Array (RPPA) technology through its newly established subsidiary, Ignite Proteomics LLC (“Ignite Proteomics”). This launch follows IMAC Holdings' strategic acquisition of key assets from Theralink Technologies, Inc., and is underscored by a landmark clinical case study “ Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer”, demonstrating the power of RPPA technology in precision oncology published in npj Precision Oncology, an international, peer-reviewed journal focused on precision oncology.

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q
BACK
globenewswire.com23 August 2024

FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC” or the “Company”) (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) on August 21, 2024 (the “Notice”). The Notice indicated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”), as described more fully in the Company's Form 12b-25 Notification of Late Filing (the “Form 12b-25”) filed with the Securities and Exchange Commission (the “SEC”) on August 15, 2024. The Listing Rule requires Nasdaq-listed companies to timely file all required periodic reports with the SEC.

IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors
IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors
IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors
BACK
globenewswire.com11 July 2024

Golden, CO, July 11, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (NASDAQ: BACK) (the “Company” or “IMAC”), a leading innovator in proteomics research and technology, announced the appointment of Dr. Peter Beitsch and Dr. Matthew Schwartz to its Board of Directors, effective June 26, 2024. This strategic move underscores the Company's commitment to advancing its position in the field of proteomics and driving innovation in precision medicine.

IMAC Holdings Announces Leadership Succession
IMAC Holdings Announces Leadership Succession
IMAC Holdings Announces Leadership Succession
BACK
globenewswire.com24 May 2024

Faith Zaslavsky appointed as CEO to succeed Jeff Ervin FRANKLIN, Tenn., May 24, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC”) today announced leadership transitions to the board of directors and executive team.

If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names
If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names
If You Can Only Buy One Penny Stock, It Better Be One of These 3 Names
BACK
InvestorPlace27 July 2023

Penny stocks are generally defined as securities that trade for less than $5 a share. These stocks can be volatile and unpredictable, leading many investors to avoid them.

FAQ

  • What is the primary business of IMAC Holdings?
  • What is the ticker symbol for IMAC Holdings?
  • Does IMAC Holdings pay dividends?
  • What sector is IMAC Holdings in?
  • What industry is IMAC Holdings in?
  • What country is IMAC Holdings based in?
  • When did IMAC Holdings go public?
  • Is IMAC Holdings in the S&P 500?
  • Is IMAC Holdings in the NASDAQ 100?
  • Is IMAC Holdings in the Dow Jones?
  • When was IMAC Holdings's last earnings report?
  • When does IMAC Holdings report earnings?
  • Should I buy IMAC Holdings stock now?

What is the primary business of IMAC Holdings?

BACK (IMAC Holdings) specializes in innovative solutions for the healthcare industry, focusing on rehabilitation and recovery. They provide advanced technologies and services to enhance patient care, improve outcomes, and support healthcare professionals in delivering effective treatments. Their mission is to transform rehabilitation through cutting-edge products and services.

What is the ticker symbol for IMAC Holdings?

The ticker symbol for IMAC Holdings is NASDAQ:BACK

Does IMAC Holdings pay dividends?

No, IMAC Holdings does not pay dividends

What sector is IMAC Holdings in?

IMAC Holdings is in the Healthcare sector

What industry is IMAC Holdings in?

IMAC Holdings is in the Medical Care Facilities industry

What country is IMAC Holdings based in?

IMAC Holdings is headquartered in United States

When did IMAC Holdings go public?

IMAC Holdings's initial public offering (IPO) was on 13 February 2019

Is IMAC Holdings in the S&P 500?

No, IMAC Holdings is not included in the S&P 500 index

Is IMAC Holdings in the NASDAQ 100?

No, IMAC Holdings is not included in the NASDAQ 100 index

Is IMAC Holdings in the Dow Jones?

No, IMAC Holdings is not included in the Dow Jones index

When was IMAC Holdings's last earnings report?

IMAC Holdings's most recent earnings report was on 10 November 2021

When does IMAC Holdings report earnings?

The date for IMAC Holdings's next earnings report has not been announced yet

Should I buy IMAC Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions